Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.

Gulmann C, Espina V, Petricoin E 3rd, Longo DL, Santi M, Knutsen T, Raffeld M, Jaffe ES, Liotta LA, Feldman AL.

Clin Cancer Res. 2005 Aug 15;11(16):5847-55.

2.

Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.

Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E 3rd, Liotta LA, Jaffe ES.

Lab Invest. 2004 Feb;84(2):235-44.

3.

In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.

Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES.

Blood. 2002 May 1;99(9):3376-82.

4.

Immunohistochemical detection of apoptotic markers in gastric cancer.

Smith L, Berrieman HK, O'Kane SL, Campbell A, Maraveyas A, Cawkwell L.

Oncol Res. 2006;15(9):441-4.

PMID:
16555550
5.
6.

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.

Zhao WL, Daneshpouy ME, Mounier N, Brière J, Leboeuf C, Plassa LF, Turpin E, Cayuela JM, Ameisen JC, Gisselbrecht C, Janin A.

Blood. 2004 Jan 15;103(2):695-7. Epub 2003 Sep 11.

7.

Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line.

Nuutinen U, Postila V, Mättö M, Eeva J, Ropponen A, Eray M, Riikonen P, Pelkonen J.

Exp Cell Res. 2006 Feb 1;312(3):322-30. Epub 2005 Nov 23.

PMID:
16309671
8.
9.

Immunohistochemical analysis of bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease.

Hiromatsu Y, Kaku H, Mukai T, Miyake I, Fukutani T, Koga M, Shoji S, Toda S, Koike N.

Endocr J. 2004 Aug;51(4):399-405.

10.

Follicular lymphoma in Osaka, Japan: histological features and chronological change.

Miyazato H, Nakatsuka S, Miyanaga I, Hanamoto H, Tatsumi Y, Matsuda M, Maeda Y, Kanamaru A, Aozasa K; Osaka Lymphoma Study Group.

Int J Hematol. 2002 Nov;76(4):333-7.

PMID:
12463596
11.

[Complex diagnosis of follicular lymphomas].

Tóth E, Schneider T, Melegh Z, Csernák E, Udvarhelyi N, Rosta A, Szentirmay Z.

Magy Onkol. 2005;49(2):135-40. Epub 2005 Oct 24. Hungarian.

12.

Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.

Cornfield DB, Mitchell DM, Almasri NM, Anderson JB, Ahrens KP, Dooley EO, Braylan RC.

Am J Clin Pathol. 2000 Aug;114(2):258-63.

13.

BNIP3 expression in follicular lymphoma.

Sington J, Giatromanolaki A, Campo L, Turley H, Pezzella F, Gatter KC.

Histopathology. 2007 Apr;50(5):555-60.

PMID:
17394490
14.

Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas.

Bai M, Papoudou-Bai A, Horianopoulos N, Grepi C, Agnantis NJ, Kanavaros P.

Hum Pathol. 2007 Jan;38(1):103-13. Epub 2006 Sep 1.

PMID:
16949642
15.

Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.

Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos DS, Papapetropoulos T, Petsas T, Dougenis D.

In Vivo. 2007 Jan-Feb;21(1):123-32.

16.

Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.

Guo Y, Karube K, Kawano R, Suzumiya J, Takeshita M, Kikuchi M, Huang GS, Li Q, Ohshima K.

Pathol Int. 2007 Mar;57(3):148-52.

PMID:
17295647
18.

Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.

Kato K, Kawashiri S, Yoshizawa K, Kitahara H, Yamamoto E.

J Oral Pathol Med. 2008 Jul;37(6):364-71. doi: 10.1111/j.1600-0714.2008.00642.x. Epub 2008 Apr 10.

PMID:
18410312
19.

Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma.

Michels J, Foria V, Mead B, Jackson G, Mullee M, Johnson PW, Packham G.

Br J Haematol. 2006 Mar;132(6):743-6.

PMID:
16487175
20.

Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.

Bilalovic N, Blystad AK, Golouh R, Nesland JM, Selak I, Trinh D, Torlakovic E.

Am J Clin Pathol. 2004 Jan;121(1):34-42.

Items per page

Supplemental Content

Write to the Help Desk